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Abstract 
Mycoplasma hyopneumoniae, the agent of porcine enzootic pneumonia (EP), is able to persist in the lung tissue and 
evade destruction by the host for several weeks. To understand the mechanism of pathogen survival, phagocytic 
uptake of M. hyopneumoniae by primary porcine alveolar macrophages was investigated. Intracellular location and 
survival of the pathogen were explored using gentamicin survival assays, flow cytometry and confocal microscopy 
of M. hyopneumoniae 232 labelled with green fluorescent protein (GFP). Following 1 h and 16 h of co-incubation, 
few viable M. hyopneumoniae were recovered from inside macrophages. Flow cytometric analysis of macrophages 
incubated with M. hyopneumoniae expressing GFP indicated that the mycoplasmas became associated with mac-
rophages, but were shown to be extracellular when actin-dependent phagocytosis was blocked with cytochalasin 
D. Confocal microscopy detected GFP-labelled M. hyopneumoniae inside macrophages and the numbers increased 
modestly with time of incubation. Neither the addition of porcine serum complement or convalescent serum from 
EP-recovered pigs was able to enhance engulfment of M. hyopneumoniae. This investigation suggests that M. hyo-
pneumoniae evades significant uptake by porcine alveolar macrophages and this may be a mechanism of immune 
escape by M. hyopneumoniae in the porcine respiratory tract.
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and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
The porcine respiratory pathogen Mycoplasma hyopneu‑
moniae is considered to be the primary agent of porcine 
enzootic pneumonia [1]. Enzootic pneumonia, a chronic 
disease, is a source of great economic loss worldwide 
because M. hyopneumoniae-infected animals exhibit 
reduced average daily weight gain and feed conversion [2, 
3]. It has been shown that M. hyopneumoniae infection 
increases susceptibility of the pig to secondary infections 
which have further economic and welfare implications [4, 
5]. At the time of slaughter, lung pathology arising from 
M. hyopneumoniae infection can be seen as regions of 
well-demarcated, dark purple, atelectatic tissue located 
in the anterior of the cranial and middle lung lobes, and 
apical anterior portion of the caudal lobe [6]. Micro-
scopic inspection of lung lesions typically reveals loss of 
cilia from the respiratory ciliated epithelium, accumula-
tion of lymphocytes and plasmocytes in peribronchial, 
peribronchiolar and perivascular areas, hyperplasia 
of bronchus associated lymphoid tissue, thickening of 
alveolar septae and exudate in bronchi and bronchiole 
lumens containing neutrophils and macrophages [7]. M. 
hyopneumoniae-induced lung lesions indicate the por-
cine host is producing an immune response to infection, 
but this response is not removing the pathogen quickly.
Management and control of enzootic pneumonia is 
achieved with good animal husbandry, disease surveil-
lance and vaccination [8]. Many pig-producing countries 
practise vaccination against M. hyopneumoniae using 
adjuvanted inactivated whole-cell preparations, but live-
attenuated vaccines are available in China and Mexico 
[8–10]. At present, all commercial M. hyopneumoniae 
vaccines offer reduced clinical and pathological signs of 
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disease; however, they all fall short of providing com-
plete protection from M. hyopneumoniae infection and 
the associated lung pathology. Hence, there is room to 
improve upon current M. hyopneumoniae vaccines [11].
In order to design and produce more effective vac-
cines against M. hyopneumoniae, better understand-
ing of M. hyopneumoniae pathogenicity is required. A 
recent review by Maes et  al. [10] recognised knowledge 
surrounding M. hyopneumoniae pathogenicity remains 
scarce but progress has been made. At present, lipopro-
teins at the surface of M. hyopneumoniae cells are recog-
nised as adhesion proteins that facilitate attachment and 
colonisation of the ciliated epithelium [12, 13]. Some of 
these adhesion proteins are also thought to function as 
moonlighting proteins. For example, aminopeptidases at 
the cell-surface of M. hyopneumoniae bind to a number 
of different host molecules, and are also able to bind and 
cleave plasminogen to plasmin [14, 15]. The significance 
M. hyopneumoniae-directed plasmin activation in the 
in vivo environment and its role in disease pathogenesis 
remains to be determined. Speculative mechanisms of 
M. hyopneumoniae virulence include hydrogen peroxide 
production, modulation and evasion of host immunity 
[10]. More research is required to reveal pathogenicity 
mechanisms employed by M. hyopneumoniae to infect 
and colonise the porcine host.
During early infection and colonisation, M. hyopneu‑
moniae is likely to encounter resident pulmonary phago-
cytes such as macrophages. Respiratory macrophages are 
an important first line of defence against invading micro-
organisms. They provide protection by engulfing and 
destroying susceptible organisms, they can also release 
chemical mediators to trigger an inflammatory immune 
response [16]. With this in mind, it is not clear from pre-
vious experimental data what role macrophages play in 
defence or propagation of M. hyopneumoniae infection. 
A number of pathogenic Mycoplasma spp. have dem-
onstrated the ability to evade phagocytic uptake by host 
macrophages. For example, M. pulmonis, M. bovis, M. 
dispar, M. pneumoniae and M. ovipneumoniae all appear 
to resist uptake by host macrophages in the absence of 
specific opsonins. Upon addition of specific antisera 
these pathogenic mycoplasmas are readily engulfed [17–
22]. It is possible that M. hyopneumoniae resists phago-
cytic uptake by respiratory macrophages, and this may 
in-part explain why M. hyopneumoniae is not quickly 
cleared by the respiratory immune system.
In this study, evasion of host immunity by M. hyopneu‑
moniae was examined by investigating the interactions 
between M. hyopneumoniae and primary porcine alveo-
lar macrophages. Experiments were designed to ascertain 
whether M. hyopneumoniae is phagocytosed by alveolar 
macrophages, and whether components of normal and 
convalescent porcine serum facilitate phagocytosis of M. 
hyopneumoniae.
Materials and methods
Bacterial strains and culture conditions
M. hyopneumoniae strain 232 was routinely cultured 
static at 37 °C in modified liquid Friis medium, and in a 
humidified atmosphere of 5%  CO2 at 37 °C on modified 
Friis agar [1, 23–25].
Escherichia coli DH5α (Thermo Fisher Scientific, Mas-
sachusetts, USA), a K-12 derivative, was routinely cul-
tured in LB broth [1% (w/v) tryptone (Oxoid, Hampshire, 
UK), 1% (w/v) NaCl and 0.5% (w/v) yeast extract (Oxoid)] 
at 37  °C with agitation at 210  rpm, and on LB agar [LB 
broth supplemented with 1.5% (w/v) bacteriological agar 
no. 1 (Oxoid)].
Isolation and culture of primary porcine alveolar 
macrophages
Two conventional large white specific-pathogen free pigs 
were sourced from a herd which did not demonstrate 
viral-, enzootic pneumonia-, nor pleuropneumonia-like 
lung pathology at abattoir surveillance. The animals were 
euthanised by sedation with a ketamine and xylazine 
mixture, followed by overdose of sodium pentobarbi-
tal via ear vein injection. Primary alveolar macrophages 
were collected as done by Cullen, Rycroft [26]. Briefly, 
ice-cold sterile phosphate buffered saline (PBS) sup-
plemented with 10  µg/mL gentamicin sulphate (Sigma 
Aldrich, Dorest, UK) was poured into the lungs, followed 
by gentle massage for 4  s and then the lavage fluid was 
collected into a sterile ice-cold glass bottle. The lungs 
from each animal appeared normal and did not present 
any macroscopic lesions suggestive of infection with res-
piratory pathogens such as M. hyopneumoniae, Actino‑
bacillus pleuropneumoniae or porcine reproductive and 
respiratory syndrome virus. The lavage fluid was centri-
fuged at 200 ×  g for 10  min at room temperature. The 
cell pellet was resuspended in RPMI 1640 1 × medium 
(GIBCO, Thermo Fisher Scientific), supplemented with 
10% heat-treated foetal bovine serum (FBS) (GIBCO). 
Viability counts were performed by trypan blue exclu-
sion. If the number of viable cells was ≥ 90%, the cells 
were frozen on the day of procurement in FBS supple-
mented with 10% dimethyl sulfoxide (DMSO). These cells 
were identified as macrophages based on cellular mor-
phology under the microscope and positive staining with 
anti-porcine CD-163 mouse antibody [27]. Two batches 
of alveolar macrophages were prepared, A and B, each 
batch originated from a different pig and were collected 
1 week apart.
The alveolar macrophages were routinely cultured 
in RPMI 1640 Glutamax supplemented with HEPES 
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(GIBCO) and 10% heat-treated FBS (referred to as tis-
sue culture medium). The macrophages were maintained 
in  vitro in 24-well plates in a humidified atmosphere of 
5%  CO2 at 37 °C for no more than 32 h.
Plasmid construction
Polymerase chain reaction (PCR) was performed using 
Phusion High Fidelity DNA polymerase (NEB, Hertford-
shire, UK) according to the manufacturers instructions. 
DNA oligonucleotides used in PCR amplification reac-
tions are listed in Table 1. The plasmid pMHGFP-P97 was 
constructed by amplifying M. hyopneumoniae strain 232 
P97 promoter sequence from pMHC9-1 [28], using prim-
ers P97F and P97R, and was subsequently cloned into 
plasmid pMHGFP2. Plasmid pMHGFP2, constructed 
from pMHO-1 [29], contained the green fluorescent 
protein gene, gfpmut2, under control of the spiralin pro-
moter sequence of Spiroplasma citri [28]; gfpmut2 was 
amplified from the pKENmut2 vector [30] using prim-
ers gfpF and gfpR. The spiralin promoter sequence was 
digested from pMHGFP2, and replaced with the P97 pro-
moter sequence at restriction sites MluI and BamHI to 
give rise to plasmid pMHGFP-P97.
Bacterial transformation
E. coli DH5α were transformed with ligation reactions by 
heat shock transformation. Briefly, ice-cold competent E. 
coli DH5α (100 μL) were incubated on ice for 30 min with 
ligation reactions (4  µL). E. coli were heat-shock trans-
formed at 42 °C for 45 s and then cooled on ice for 2 min, 
followed by recovery in SOC medium (2% (w/v) tryptone 
(Oxoid), 0.5% (w/v) yeast extract (Oxoid), 0.05% (w/v) 
NaCl, 12.5 mM KCl, 10 mM  MgCl2 and 20 mM glucose) 
(900  μL) for 1  h at 37  °C and 210  rpm. Transformed E. 
coli (100 μL) were spread on LB agar supplemented with 
50 μg/mL ampicillin and incubated overnight at 37 °C.
M. hyopneumoniae strain 232 was transformed with 
plasmid DNA by electroporation as described previously 
[29]. Briefly, 25  mL of modified Friis medium inocu-
lated with 0.5  mL of M. hyopneumoniae stock culture 
was grown static for approximately 41 h at 37 °C. The M. 
hyopneumoniae were washed and incubated on ice for 
30 min with 10 μg of plasmid DNA. M. hyopneumoniae 
were transformed by electroporation at 2.5  kV, 100  Ω 
and 25 μF. Afterwards, 900 μL ice-cold Friis medium was 
added and the transformations were incubated on ice for 
15  min. Transformed M. hyopneumoniae were allowed 
to recover for 3 h in static incubation, at 37 °C, and were 
then cultured on Friis agar supplemented with 0.2  μg/
mL tetracycline at 37 °C in 5%  CO2 for 7–14 days. Trans-
formed M. hyopneumoniae colonies were transferred to 
1 mL Friis medium supplemented with 0.5 μg/mL tetra-
cycline, and incubated at 37 °C until the culture became 
peach/orange in colour. Liquid cultures at this stage were 
stored at −70 °C.
Gentamicin survival assays
One hour gentamicin survival assay
Primary porcine alveolar macrophages (1 × 106 in 1 mL) 
that had been frozen (batch A) were seeded into 24-well 
cell-culture treated plates (Nunc Nunclon Delta, Thermo 
Fisher Scientific) and allowed to adhere in a humidified 
atmosphere of 5%  CO2 at 37 °C, for at least 1 h.
A M. hyopneumoniae culture (20  mL) grown for 
approximately 32  h was centrifuged, and then briefly 
washed in sterile PBS. The M. hyopneumoniae cell pellet 
was resuspended in 10 mL tissue culture medium. E. coli 
DH5α was grown to 1 × 108 colony forming units (CFU)/
mL, and 1 mL was centrifuged and washed in sterile PBS. 
The E. coli cell pellet was resuspended in 1  mL sterile 
PBS and then diluted 1 in 100 in tissue culture medium 
(10 mL).
Medium was removed from PAMs and replaced with 
either 1 mL of M. hyopneumoniae or E. coli inoculum, or 
tissue culture medium. The experiment was performed 
in duplicate and the intended multiplicity of infection 
(MOI) of bacteria/macrophage was 1:1. The inoculated 
PAMs were incubated in a humidified atmosphere of 5% 
 CO2 at 37 °C for 1 h, and then the medium was removed 
and wells were washed very gently three times with sterile 
PBS. Tissue culture medium supplemented with or with-
out 400  μg/mL gentamicin [31], was added to specified 
wells and the plate was incubated for a further 3 h. After 
incubation, culture supernatants of gentamicin-treated 
wells were collected and centrifuged at 16  000  ×  g for 
2 min. Pellets were washed once in PBS, and then resus-
pended in 40 μL PBS and the entire volume was spread 
onto solid microbiological medium. The culture superna-
tants of wells without gentamicin were serially diluted 1 
in 10 in PBS (1 mL) and 10 μL spots were inoculated onto 
solid microbiological medium.
After the culture supernatants had been removed, the 
wells were gently washed three times with warm ster-
ile PBS. To wells inoculated with M. hyopneumoniae 
400  μL of Friis medium was added, and 400  μL of LB 
broth to wells inoculated with E. coli. The well surfaces 
were scraped with sterile mini cell scrapers (Biotium, 
Table 1 DNA oligonucleotides 
Underlined nucleotides indicate restriction enzyme sequence
Name 3′ sequence 5′
gfpF TTACT AGT TGT GTG GAA TTC GAG CTC GG
gfpR TTG CAT GCCTG CAG GTC TGG 
P97F GTC ACG CGT CTT TTA ATT ATT AGT CTT CC
P97R GTC GGA TCC TTA CTC ATA TTT TAA ACC TC
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California, USA) and the contents were transferred to 
2 mL microcentrifuge tubes containing a single tungsten 
carbide 3 mm bead (Qiagen, Manchester, UK). The tube 
contents were homogenised for 2  min at 30 cycles per 
second in a Retsch MM300 homogeniser (Retsch, Haan, 
Germany). It was previously confirmed that this method 
of homogenisation did not reduce the viability of M. hyo‑
pneumoniae. The homogenised samples that had not 
been treated with gentamicin, were serially diluted 1 in 
10 in PBS (1 mL) and 10 μL spots were spotted onto solid 
microbiological medium. The entire volume (400 μL) of 
gentamicin-treated samples was spread onto 9 cm plates. 
Samples from uninoculated controls were plated to check 
for contaminating microorganisms.
Overnight gentamicin survival assay
Primary porcine alveolar macrophages (1 × 106 in 1 mL) 
that had been frozen (batch A), were seeded into 24-well 
cell-culture treated plates and were incubated for at least 
1 h.
M. hyopneumoniae and E. coli were prepared similarly 
to the 1 h gentamicin survival assay, except the inoculum 
was reduced such that the starting MOI of bacteria/mac-
rophage was 1:100.
The medium was removed from macrophages and 
replaced with either 1 mL of M. hyopneumoniae or E. coli 
inoculum. The macrophages and bacteria were incubated 
static in a humidified atmosphere of 5%  CO2 at 37 °C for 
approximately 16 h, and then tissue culture medium sup-
plemented with or without 400  µg/mL gentamicin was 
applied for 6 h. After the first 3 h of incubation the tissue 
culture medium ± gentamicin was refreshed. The experi-
ment was performed in triplicate.
Flow cytometry
Flow cytometric analysis of GFP‑transformed bacteria
Untransformed bacteria diluted 1 in 10 in PBS, were ana-
lysed on BD Accuri C6 flow cytometer (BD Bioscience, 
California, USA) to gate bacterial cells. GFP-transformed 
bacteria were also diluted 1 in 10 in PBS and analysed. 
Green fluorescent bacteria were detected by the FL1 
detector. To distinguish fluorescent and non-fluorescent 
bacterial cells, a marker was drawn on the FL1 histogram 
plot of untransformed bacteria. This marker was then 
applied to FL1 histogram plots of GFP-transformed bac-
teria to establish the percentage of fluorescent bacteria.
Flow cytometric analysis of phagocytic uptake 
of GFP‑labelled bacteria
Alveolar macrophages (5 × 105 in 0.5  mL per reaction) 
that had been frozen (batch A) were supplemented with 
or without 20  μg/mL cytochalasin D (CCD) (Sigma 
Aldrich, catalogue C2618). The macrophages (0.5  mL) 
were seeded into wells of a 24-well plate and incubated 
for 15 min at 37 °C prior to the addition of bacteria.
A 200  mL  M. hyopneumoniae (pMHGFP-P97) cul-
ture was prepared by inoculating 0.5  mL stock culture 
into 200  mL Friis medium. This culture was grown for 
122  h until the medium was orange in colour. The M. 
hyopneumoniae (pMHGFP-P97) culture was centri-
fuged at 9000 × g for 10 min at room temperature. The 
mycoplasma pellet was briefly washed in sterile PBS, 
and then resuspended in 4  mL tissue culture medium 
such that 200 μL was equal to 25 mL original culture. E. 
coli (pKENmut2) was grown until optical  density600nm 
 (OD600nm) 0.6, centrifuged at 2500 × g for 5 min, washed 
briefly in PBS and then diluted to 1.3 × 107 CFU/200 
μL. The intended MOI of bacteria/PAM was 25:1. The 
macrophages, with and without CCD, were inoculated 
with 0.5  mL  M. hyopneumoniae (pMHGFP-P97) or E. 
coli (pKENmut2); this halved the CCD concentration to 
10  μg/mL. Some of the wells containing macrophages, 
with and without CDD, were mock-inoculated with tis-
sue culture medium as the negative controls. The experi-
ment was performed in triplicate. The macrophages were 
incubated with the bacteria for 1  h, static, in a humidi-
fied atmosphere of 5%  CO2 at 37 °C. After incubation, the 
macrophages were gently scrapped from the well surface 
with mini cell scrappers, and then centrifuged at 400 × g 
for 5 min at room temperature in microcentrifuge tubes. 
The supernatants were removed and the macrophage 
cells pellets were resuspended in 500 μL FACSFlow. The 
macrophages were analysed immediately on a FACSCali-
bur flow cytometer (BD) using the FL1 detector. Unin-
oculated macrophages were used to gate non-fluorescent 
cells. The flow cytometric data were analysed in FlowJo 
version 10 software (FlowJo LLC, Oregon, USA).
Confocal microscopy
Visualising GFP‑transformed M. hyopneumoniae
Liquid cultures of GFP-transformed M. hyopneumoniae 
were grown until orange (72  h) in colour. The cultures 
were centrifuged at 9000 × g for 10 min at room temper-
ature, and washed once in 1 mL PBS. M. hyopneumoniae 
cells were mounted onto glass coverslips as previously 
described [14]. Briefly, M. hyopneumoniae cells were 
resuspended in 100  μL PBS for every 1  mL of original 
culture. Glass coverslips (22 × 22  mm, Chance Prop-
per, Warley, UK) were coated with 0.01% poly-l-lysine 
(w/v) (Sigma Aldrich) and air-dried at room temperature. 
M. hyopneumoniae suspensions (100 μL) were spotted 
onto the poly-l-lysine coated coverslips and allowed to 
adhere for 30  min at room temperature. The coverslips 
were washed twice in PBS, then M. hyopneumoniae were 
fixed in 2% formaldehyde in PBS overnight at 4–8  °C. 
Formaldehyde was removed by three brief washes in 
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PBS. M. hyopneumoniae cells were stained with 1 μg/mL 
4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) 
(Roche Diagnostics, Mannheim, Germany) in PBS for 
30 min at room temperature in the dark, followed by two 
brief washes with PBS. The coverslips were air-dried, and 
then 5 μL of Vectashield (Vector Laboratories, California, 
USA) was spotted on the coverslip and a glass slide was 
placed on top. The edges of the coverslip were sealed with 
transparent nail varnish (Maybelline, New York, USA).
GFP-transformed M. hyopneumoniae mounted onto 
glass coverslips were viewed on a confocal scanning 
laser Leica SP5 microscope (Leica Microsystems, Wet-
zlar, Germany). The samples were viewed by 63× objec-
tive with 4× digital zoom. Blue light (405 nm) was used 
to excite DAPI to visualise nucleic acid, and blue light 
(488 nm) to excite and visualise GFP. Untransformed M. 
hyopneumoniae were used as the negative control.
Confocal microscopy analysis of porcine alveolar 
macrophages infected with GFP‑labelled M. hyopneumoniae
Time‑dependent experiments Primary porcine alveolar 
macrophages that had been frozen (batch B) were seeded 
(2.5 × 105 cells per well) into an 8-chamber glass Lab-Tek 
Chamber Slide System (Nunc). The macrophages were 
incubated for at least 1 h prior to use.
A M. hyopneumoniae (pMHGFP-P97) culture that 
was orange in colour was centrifuged at 9000  ×  g for 
10  min at room temperature. The mycoplasma pellet 
was washed briefly in PBS and then resuspended in tis-
sue culture medium (supplemented with 0.5 μg/mL tet-
racycline hydrochloride) such that 200  μL was equal to 
12.5  mL of original culture. When M. hyopneumoniae 
wild type strain 232 were used, the mycoplasma pel-
let was suspended in tissue culture medium such that 
200  μL was equal to 5  mL of original culture. E. coli 
(pKENmut2) were grown until  OD600nm 0.6. The E. coli 
were centrifuged at 2500 × g for 5 min at room tempera-
ture, and briefly washed in PBS. The E. coli cell pellet was 
resuspended and diluted in tissue culture medium (sup-
plemented with 50  μg/mL ampicillin) such that 200 μL 
contained 2.5 × 106 CFU.
The tissue culture medium was removed from mac-
rophages, and replaced with either 200  μL of M. hyo‑
pneumoniae (pMHGFP-P97), or M. hyopneumoniae wild 
type, or E. coli (pKENmut2). The macrophages and bac-
teria were incubated for the specified time in a humidi-
fied atmosphere of 5%  CO2 at 37 °C. After incubation, the 
culture medium was removed from wells and each well 
was gently washed with warm PBS. The samples were 
fixed with 2% paraformaldehyde in PBS (Sigma Aldrich) 
overnight at 4–8 °C in the dark.
Following fixation, the wells were washed with PBS 
twice, and then 100  μL 0.5% Triton-X-100 in PBS was 
added, and the samples were incubated at room tem-
perature for 15  min. The wells were then washed with 
PBS three times, and 5% bovine serum albumin in PBS 
was added and the samples were incubated at 4–8 °C for 
30 min. The wells were then washed with PBS twice, and 
200 μL of 1 μg/mL DAPI and 5 U/mL phalloidin-CF568 
(Biotium) in PBS was added, and the samples were incu-
bated at room temperature for 30  min in the dark. The 
wells were washed with PBS twice and then 200  μL of 
1 μg/mL mouse IgG1 anti-GFP (Sigma Aldrich, catalogue 
SAB4600051) was applied to each well and incubated at 
4–8 °C for 1 h in the dark. After this incubation, the wells 
were washed with PBS three times, and the chamber and 
gasket were removed from the slide. The slide was air-
dried and 30 μL of Vectashield was spotted onto the slide. 
A glass coverslip was placed on top and the edges were 
sealed with transparent nail varnish.
The samples were viewed on a confocal scanning laser 
Leica SP5 microscope. The samples were viewed by 63× 
objective with 4× digital zoom. Blue light (405 nm) was 
used to excite DAPI to visualise nucleic acid, blue light 
(488  nm) to excite and visualise GFP, and yellow light 
(594  nm) to excite phalloidin-CF568 to visualise mac-
rophage actin. Micrographs were captured at increments 
of 0.13 μm along the z-axis to produce z-stack images of 
macrophages. To determine if bacteria were inside mac-
rophages, the z-stack micrographs were viewed in x, y 
and z-planes simultaneously using the computer software 
Volocity version 6.3 (PerkinElmer, Massachusetts, USA).
Opsonisation experiments
Opsonisation of M. hyopneumoniae (pMHGFP-P97) and 
E. coli (pKENmut2) was performed using preimmune 
porcine serum and convalescent porcine sera A, B and 
C. The preimmune and convalescent sera A were derived 
from the same pig at different times; the preimmune 
serum was collected before M. hyopneumoniae infection 
and serum A was collected 5 weeks after infection with 
M. hyopneumoniae strain 232 (supplied by Jessica Bed-
dow). Serum B was derived from a pig infected with M. 
hyopneumoniae strain 325 (known as 9954 serum), and 
serum C was derived from a pig infected with M. hyo‑
pneumoniae strain 89 (known as 9965 serum) (supplied 
by Andrew Rycroft). The presence of M. hyopneumoniae-
specific antibody in the convalescent sera was confirmed 
by Western Blot (data not shown). Heat-treated FBS was 
the negative control serum.
M. hyopneumoniae (pMHGFP-P97) cell pellets, each 
equivalent to 12.5  mL original culture, were resus-
pended in 100  μL of tissue culture medium supple-
mented with 1  μg/mL tetracycline hydrochloride. To 
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separate M. hyopneumoniae (pMHGFP-P97) suspen-
sions (100 μL), 100 μL of the different sera were added 
and incubated at 37 °C for 15 min. E. coli (pKENmut2) 
pellets, each equivalent to 2.5 × 106 CFU, were resus-
pended in 100  μL of tissue culture medium supple-
mented with 100 μg/mL ampicillin sodium salt. These 
E. coli (pKENmut2) suspensions were treated the same 
as M. hyopneumoniae (pMHGFP-P97). Macrophages 
(batch B) were inoculated with these 200  μL sus-
pensions of bacteria and incubated for 2  h. All other 
experiment details were identical to the time-depend-
ent experiments.
Results
Few viable M. hyopneumoniae were recovered 
from inside porcine macrophages
To evaluate the ability of porcine lung macrophages to 
engulf M. hyopneumoniae, cells were prepared by lav-
age of the lungs from a freshly killed pig known to be 
free of M. hyopneumoniae and other respiratory patho-
gens [26]. Primary porcine alveolar macrophages were 
incubated with either M. hyopneumoniae 232 or E. coli 
DH5α for 1 h before addition of gentamicin for 3 h to 
kill extracellular bacteria. Enumeration of bacteria in 
the cell supernatants showed complete destruction of 
the extracellular E. coli. However, a small proportion 
of M. hyopneumoniae (0.0045%) survived the treat-
ment with gentamicin (Figure  1A). Internalised bac-
teria were then recovered by rupture of lung cells 
by mechanical homogenisation. Culture of the cell 
homogenate revealed 0.125% of the M. hyopneumoniae 
were viable compared to the control without antibiotic 
(Figure 1A). The effectiveness of gentamicin treatment 
and efficiency of macrophage phagocytic function was 
confirmed as no E. coli DH5α were recovered from 
supernatant but E. coli were recovered from the cell 
homogenate (Figure 1B).
To determine whether phagocytic activity was time-
dependent, M. hyopneumoniae were incubated with 
lung macrophages for 16  h. Gentamicin (400  μg/mL) 
was then applied for 6  h. Extended exposure to gen-
tamicin was intended to eliminate all extracellular M. 
hyopneumoniae. No M. hyopneumoniae were recov-
ered from the culture supernatants following extended 
exposure to gentamicin. This indicated that all extra-
cellular M. hyopneumoniae had been eliminated (Fig-
ure  2A). No M. hyopneumoniae were recovered from 
gentamicin-treated disrupted macrophages while 
numerous viable M. hyopneumoniae were recovered 
from untreated macrophages (Figure  2A). This result 
suggested that very few M. hyopneumoniae had been 
phagocytosed by macrophages.
Expression and detection of green fluorescent protein 
in M. hyopneumoniae
In order to express GFP in M. hyopneumoniae, a plasmid 
carrying the GFP gene gfpmut2 was constructed from 
a plasmid known to be stably inherited in M. hyopneu‑
moniae. The plasmid construct was based on pMHO-1 
which contained the predicted origin of replication of M. 
hyopneumoniae strain 232, the tetM tetracycline resist-
ance gene expressed under control of its natural pro-
moter from Enterococcus faecalis, and the bla ampicillin 
resistance gene [29]. Plasmid pMHGFP-P97 was pro-
duced by cloning the gfpmut2 gene under control of the 
P97 gene promoter sequence, from M. hyopneumoniae 
strain 232, into plasmid pMHO-1 (Figure 3).
M. hyopneumoniae strain 232 was electroporated with 
plasmid pMHGFP-P97 and transformants were recov-
ered on selective medium. Transformed M. hyopneu‑
moniae were viewed using a confocal laser scanning 
microscope for green fluorescence.
M. hyopneumoniae (pMHGFP-P97) cells fluoresced 
green, enabling visualization of individual mycoplasma 
cells (Figure 4).
M. hyopneumoniae (pMHGFP-P97) was analysed fur-
ther analysis by flow cytometry. The effect of culture time 
on fluorescence intensity was determined. At each time 
Figure 1 1 h phagocytosis assay of M. hyopneumoniae. Porcine 
alveolar macrophages were incubated with M. hyopneumoniae or 
E. coli for 1 h and then 400 µg/mL gentamicin was applied for 3 h. 
Samples were plated on to solid medium to enumerate bacteria. A 
M. hyopneumoniae recovered from culture supernatant or disrupted 
macrophages, with and without gentamicin treatment. B E. coli 
recovered from culture supernatant or disrupted macrophages, with 
and without gentamicin treatment.
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point the fluorescent population was depicted by a broad 
peak suggesting that cells differed in fluorescence inten-
sity. At 24 h post-inoculation, 17% of the M. hyopneumo‑
niae (pMHGFP-P97) population were fluorescing green, 
this increased in intensity with incubation to 96  h (Fig-
ure  5). The intensity of fluorescence of M. hyopneumo‑
niae (pMHGFP-P97) was considered sufficient as a label 
in further investigations.
Flow cytometric analysis showed M. hyopneumoniae 
was not phagocytosed by macrophages
A flow cytometric phagocytosis assay using GFP-labelled 
M. hyopneumoniae 232 (pMHGFP-P97) was used to 
investigate phagocytic uptake by porcine alveolar mac-
rophages [32, 33]. The assay determines phagocytic 
uptake of fluorescent bacteria by comparing the fluores-
cence intensity of phagocytes that have been treated with 
and without cytochalasin D (CCD), an inhibitor of actin-
dependent phagocytosis. Uptake of fluorescent bacte-
ria is evident when CCD-treated phagocytes have lower 
fluorescence intensity than the untreated phagocytes, 
because CCD-treated phagocytes only have externally-
associated bacteria. Alveolar macrophages treated with 
CCD, or left untreated, were incubated with M. hyopneu‑
moniae (pMHGFP-P97) for 1 h. Green fluorescent E. coli 
(pKENmut2) was used as the control organism.
Untreated macrophages incubated with the posi-
tive control E. coli had significantly higher fluorescence 
intensity than CCD-treated macrophages (Figure 6). This 
result confirmed untreated macrophages had taken up 
E. coli (pKENmut2), and that phagocytosis was inhib-
ited by CCD. In contrast, the mean fluorescence inten-
sity of macrophages incubated with M. hyopneumoniae 
(pMHGFP-P97), with and without CCD, were very simi-
lar (Figure 6). The fluorescence intensity of CCD-treated 
macrophages was marginally higher than untreated mac-
rophages, but this difference was not significant. It was 
suggested from these results that more M. hyopneumo‑
niae (pMHGFP-P97) were bound to CCD-treated mac-
rophages than untreated macrophages. It was therefore 
concluded that M. hyopneumoniae (pMHGFP-P97) had 
not been engulfed by primary macrophages.
Internalised M. hyopneumoniae detection by confocal 
microscopy
M. hyopneumoniae (pMHGFP-P97) was utilised in con-
focal microscopy experiments to look for evidence of 
uptake by porcine alveolar macrophages. Cells were 
incubated with M. hyopneumoniae (pMHGFP-P97) for 2, 
4 and 6 h, and were examined for green-labelled myco-
plasma localised in the cytoplasm. E. coli (pKENmut2) 
was again used as the positive control organism.
E. coli was observed inside macrophages at each time 
point, demonstrating the macrophages were phagocytic 
(Figure  7). Macrophages exposed to M. hyopneumoniae 
(pMHGFP-P97) exhibited numerous externally-bound 
mycoplasma cells, many of which appeared flattened 
Figure 2 Overnight phagocytosis assay of M. hyopneumoniae. 
Porcine alveolar macrophages were incubated with M. 
hyopneumoniae or E. coli overnight (16 h) and then 400 µg/mL 
gentamicin was applied for 6 h. Samples were plated on to solid 
medium to enumerate bacteria. A M. hyopneumoniae recovered from 
culture supernatant or disrupted macrophages, with and without 
gentamicin treatment. B E. coli recovered from culture supernatant 
or disrupted macrophages, with and without gentamicin treatment. 
Error bars show standard error of the mean from one experiment 
performed in triplicate.
Figure 3 pMHGFP-P97 plasmid diagram. Oric = M. 
hyopneumoniae strain 232 predicited origin of replication, EF 
promoter = tetM gene promoter from Enterococcus faecalis, 
tetM = tetracycline resistance gene, gfpmut2 = green fluorescent 
protein gene, P97 promoter = predicted P97 gene promoter from M. 
hyopneumoniae strain 232, bla = ampicillin resistance gene.
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against the macrophage cell-surface (Figure  7). A few 
M. hyopneumoniae (pMHGFP-P97) were also observed 
inside the macrophages. An average of 2  M. hyopneu‑
moniae (pMHGFP-P97) cells were found inside mac-
rophages after 2 and 4  h of incubation (Table  2). This 
increased to 4 intracellular M. hyopneumoniae (pMH-
GFP-P97) after 6 h of incubation. Untransformed M. hyo‑
pneumoniae, visualised by nucleic acid staining, behaved 
similarly to GFP-labelled M. hyopneumoniae (data not 
shown). 
Opsonisation did not enhance phagocytic uptake
To assess whether opsonisation improved engulfment, 
M. hyopneumoniae (pMHGFP-P97) were exposed to 
three different convalescent porcine sera (sera A, B and 
C) or preimmune serum prior to incubation with alveolar 
macrophages for 2 h. The convalescent sera were sources 
of complement and specific antibody; preimmune serum 
provided complement only. Heat-inactivated foetal 
bovine serum was used as the negative control.
Analysis of confocal micrographs revealed that on 
average, the number of intracellular M. hyopneumoniae 
(pMHGFP-P97) did not differ between samples contain-
ing the different porcine sera or heat-inactivated foetal 
bovine serum (Table  3). It was concluded that neither 
complement, nor M. hyopneumoniae-specific serum 
antibody, appeared to enhance phagocytic uptake of the 
mycoplasma by porcine alveolar macrophages.
Discussion
The aim of this study was to learn more about the 
interactions between M. hyopneumoniae and porcine 
macrophages. It was considered likely that M. hyo‑
pneumoniae may evade alveolar macrophage clearance 
mechanisms but few functional experiments investigat-
ing this have been reported. Investigations which have 
utilised macrophages focused primarily on cytokine 
production and changes in macrophage viability follow-
ing exposure to M. hyopneumoniae or M. hyopneumo‑
niae-cell fractions. For instance, Bai et al. [34] found that 
Figure 4 Confocal micrographs of M. hyopneumoniae (pMHGFP-P97). M. hyopneumoniae cells were stained with 
4′,6-diamidino-2-phenylindole (DAPI) and were excited by 405 nm and 488 nm lasers to visualise nucleic acid and green fluorescence, respectively. 
A (i) M. hyopneumoniae (pMHGFP-P97) cells stained by DAPI, (ii) M. hyopneumoniae (pMHGFP-P97) cells viewed on green fluorescence channel, 
(iii) overlay of i and ii. B (i) untransformed M. hyopneumoniae cells stained by DAPI, (ii) untransformed M. hyopneumoniae cells viewed on green 
fluorescence channel, (iii) overlay of i and ii.
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lipid-associated membrane proteins (LAMPs) derived 
from M. hyopneumoniae strain 232 exerted a cytopathic 
effect on the immortalised porcine alveolar macrophage 
cell line PAM 3D4/21 [34]. Although M. hyopneumoniae 
LAMPs induced apoptosis in more than 80% of PAM 
3D4/21 cells, a much lesser effect was observed for whole 
live M. hyopneumoniae cells. Liu et al. [35] recently iden-
tified mhp390 (P68) as a surface membrane protein of M. 
Figure 5 Flow cytometric analysis of M. hyopneumoniae (pMHGFP-P97) fluorescence over time. A M. hyopneumoniae (pMHGFP-P97) culture 
was analysed for green fluorescence over time by flow cytometry. The histogram FL1-A axis depicts green fluorescence intensity. On histograms 
plots, the vertical line indicates the boundary between fluorescent and non-fluorescent cells, to right of the line are fluorescent cells. A 24 h. B 48 h. 
C 72 h. D 96 h. E 168 h. F Untransformed M. hyopneumoniae. G Viable counts of M. hyopneumoniae (pMHGFP-P97) were performed from 24 to 96 h. 
Error bars show standard error of the mean.
Page 10 of 15Deeney et al. Vet Res           (2019) 50:51 
hyopneumoniae which was able to induce caspase-3 acti-
vation, and thus apoptosis in primary porcine alveolar 
macrophages following 36 h of exposure.
In the present study, gentamicin survival experiments 
were conducted to ascertain whether viable M. hyopneu‑
moniae could be recovered from inside porcine alveolar 
macrophages; which would suggest phagocytic uptake of 
this mycoplasma. The experimental results indicated very 
few viable M. hyopneumoniae were inside porcine alveo-
lar macrophages. This could be interpreted that few M. 
hyopneumoniae had been engulfed, or that once inside 
macrophages M. hyopneumoniae were killed or few 
mycoplasmas remained viable. Since the macrophages 
appeared to engulf but not kill the control organism, E. 
coli DH5α, it was thought unlikely that M. hyopneumo‑
niae had been killed by the macrophages. Therefore, it 
was concluded that very few M. hyopneumoniae had 
been engulfed by the macrophages. Other investigators 
have conducted similar experiments with different Myco‑
plasma species. Davis et al. [18] for example found that 
the number of inoculated M. pulmonis were not reduced 
following incubation with mouse alveolar macrophages. 
The investigators only observed a reduction in M. pul‑
monis co-cultured with macrophages when hyperim-
mune rabbit antiserum was applied. More recent studies 
have indicated M. pulmonis resists binding to the mouse 
alveolar macrophages cell line, MH-S cells, which pre-
vents phagocytic uptake and subsequent killing [19, 36]. 
Results from the present gentamicin survival experi-
ments indicated M. hyopneumoniae, like M. pulmonis, 
evaded uptake by host alveolar macrophages; at least in 
the absence of opsonins. A recent publication by Ray-
mond et al. [37] also used an in vitro gentamicin survival 
method to show M. hyopneumoniae (up to 8%) can be 
found intracellularly in the porcine kidney epithelial cell 
line, PK-15.
Since the gentamicin survival experiments relied on 
the viability of M. hyopneumoniae to inform on phago-
cytic uptake, an additional approach was taken that did 
not measure mycoplasma viability. Flow cytometric 
and confocal microscopy experiments were set up to 
provide more information about the physical interac-
tions between M. hyopneumoniae and macrophages. 
To perform these experiments M. hyopneumoniae was 
transformed with green fluorescent protein using the 
extrachromosomal plasmid pMHGFP-P97, compris-
ing gfpmut2 controlled by the P97 gene promoter. Two 
additional plasmids were investigated to express GFP 
in M. hyopneumoniae; plasmid pMHGFP2, comprising 
gfpmut2 controlled by the spiralin gene promoter; and 
pMHGFP-tuf which contained gfpmut2 controlled by the 
tuf gene promoter of M. hyopneumoniae strain 232. Plas-
mid pMHGFP-tuf failed to transform M. hyopneumoniae 
and M. hyopneumoniae (pMHGFP2) did not fluoresce as 
brightly as M. hyopneumoniae (pMHGFP-P97) (data not 
shown).
Expression of GFP in M. hyopneumoniae was first 
reported by Ishag et al. [38] who used extrachromosomal 
plasmid pMD18- TOgfp to express GFP. The plasmid 
pMD18-TOgfp possessed a gfp gene under control of the 
P97 gene promoter sequence, and a tetM gene under con-
trol of an additional copy of the P97 gene promoter. In 
contrast, pMHGFP-P97 produced in this study only pos-
sessed one copy of the P97 promoter sequence to control 
expression of gfpmut2. Hence, pMHGFP-P97 may offer 
more stability than pMD18-TOgfp. The fluorescence 
Figure 6 Geometric mean fluorescence intensities of macrophages, without and without CCD, after incubation with GFP-labelled 
M. hyopneumoniae and E. coli. The green fluorescence intensity of PAMs following incubation with GFP-labelled M. hyopneumoniae (M. 
hyopneumoniae (pMHGFP-P97)) or GFP-labelled E. coli (E. coli (pKENmut2)) was measured and normalised against uninoculated PAMs. Error 
bars show standard error of the mean from two separate experiments, 6 replicates in total. Significant mean differences were determined by 
independent T-test (PAMs ± CCD and E. coli) and Mann–Whitney U test (PAMs ± CCD and M. hyopneumoniae), ***p < 0.001. Porcine alveolar 
macrophages (PAMs), cytochalasin D (CCD).
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Figure 7 External and internalised M. hyopneumoniae (pMHGFP-P97) following incubation with porcine alveolar macrophages. Confocal 
micrographs of macrophages incubated with M. hyopneumoniae (pMHGFP-P97) or the control, E. coli (pKENmut2), for 2, 4 and 6 h. Fluorescent stains 
show: macrophage actin cytoskeleton in red, nucleic acid in blue, and GFP-labelled bacteria in green. Yellow arrows indicate internal bacteria in the 
XYZ planes, white arrows indicate internal bacteria, and white triangles indicate external bacteria.
Page 12 of 15Deeney et al. Vet Res           (2019) 50:51 
intensity of M. hyopneumoniae (pMHGF-P97) cells was 
found to be dependent on time, at least 72  h of culture 
was required for maximal numbers of M. hyopneumoniae 
(pMHGFP-P97) cells to fluoresce. In addition, flow cyto-
metric analysis of M. hyopneumoniae (pMHGFP-P97) 
revealed the fluorescence intensity of mycoplasma cells 
was heterogeneous, as indicated by the broad histogram 
peak. This may be related to different levels of intracel-
lular GFP in differently aged M. hyopneumoniae (pMH-
GFP-P97) cells. Neither Ishag et al. [38] nor investigators 
expressing fluorescent protein in other mycoplasmas 
have noted a dependence of fluorescence intensity on 
culture time or fluorescence heterogeneity [39–41]. 
Despite the heterogeneous nature of M. hyopneumoniae 
(pMHGFP-P97) fluorescence, it was still suitable to use 
in downstream flow cytometry and confocal microscopy 
experiments.
Results from the flow cytometry experiments showed 
M. hyopneumoniae (pMHGFP-P97) became associ-
ated with macrophages within 1  h of co-incubation. 
Since the fluorescence intensities of M. hyopneumo‑
niae (pMHGFP-P97)-infected macrophages treated 
with and without CCD were similar, it was inferred 
that all M. hyopneumoniae (pMHGFP-P97) were 
attached to the external surface of macrophages. An 
unexpected finding was that more M. hyopneumoniae 
(pMHGFP-P97) appeared bound to CCD-treated mac-
rophages than untreated macrophages. This might be 
explained by an unanticipated side effect where CCD 
caused the macrophages to detach from the surface of 
the culture dish. Hence, while in suspension the CCD-
treated macrophages may have encountered M. hyo‑
pneumoniae (pMHGFP-P97) more frequently than the 
adhered untreated macrophages. The confocal micros-
copy experiments also confirmed M. hyopneumoniae 
(pMHGFP-P97) adhered to the surface of macrophages, 
some mycoplasmas even appeared flattened to the mac-
rophage cell surface. In contrast to results from the flow 
cytometry experiments, analysis of confocal micro-
graphs revealed a small number of M. hyopneumoniae 
(pMHGFP-P97) were in-fact located in the cytoplasm 
of porcine alveolar macrophages. The slightly differ-
ing results of the confocal microscopy and flow cytom-
eter experiments may have been due to lower sensitivity 
of the flow cytometer to detect internalisation of such a 
low number of M. hyopneumoniae (pMHGFP-P97). It is 
also noted that the gentamicin survival and flow cytom-
etry experiments utilised macrophages originating from 
the same pig, whereas macrophages from another ani-
mal were used in the confocal microscopy experiments 
(both animals were derived from the same source at the 
same time). Consequently, variability in the activity of 
macrophages obtained from different animals should be 
considered. However, the phagocytic capability of both 
macrophage batches appeared comparable throughout 
this investigation, as demonstrated by engulfment of the 
control organism, E. coli, via three different methods.
It appeared that uptake of M. hyopneumoniae by por-
cine alveolar macrophages was limited and that this 
mycoplasma may even resist significant uptake. Powell 
and Clyde [42] found that in the absence of antibody M. 
pneumoniae also readily associated with the membrane 
of guinea pig alveolar macrophages, but were rarely found 
inside macrophages. The addition of hyperimmune rab-
bit antiserum however led to uptake of M. pneumoniae 
[42]. In the present study, the gentamicin survival, flow 
cytometry and initial confocal microscopy experiments 
had been performed in the absence of host opsonins. To 
address this, M. hyopneumoniae (pMHGFP-P97) were 
opsonised with porcine serum containing complement, 
or convalescent serum containing complement and anti-
M. hyopneumoniae antibody. M. hyopneumoniae (pMH-
GFP-P97) were not susceptible to the bactericidal activity 
of serum complement, unlike the control E. coli (pKEN-
mut2) which was killed by exposure to serum (data not 
shown). Analysis of confocal micrographs suggested 
serum complement did not enhance phagocytic uptake 
Table 2 Number of M. hyopneumoniae (pMHGFP-P97) 
inside porcine alveolar macrophages following 2, 4 and 
6 h of co-incubation 
Standard error of the mean ± is shown, the number of porcine alveolar 
macrophages (PAMs) analysed is shown in parentheses.
Time (hours) Avergae number of intracellular M. 
hyopneumoniae (pMHGFP-P97)/
PAM
2 2 ± 0.4 (35 PAMs)
4 2 ± 0.6 (8 PAMs)
6 4 ± 0.5 (35 PAMs)
Table 3 Effect of opsonisation on internalisation of 
M. hyopneumoniae (pMHGFP-P97) by porcine alveolar 
macrophages 
Standard error of the mean ± is shown, the number of porcine alveolar 
macrophages (PAMs) analysed is shown in parentheses. Sera A, B and C are 
convalescent M. hyopneumoniae serum, heat inactivated bovine serum served 
as the control.
Serum Average number of intracellular 
M. hyopneumoniae 
(pMHGFP-P97)
Preimmune 3 ± 0.5 (36 PAMs)
A 3 ± 0.8 (24 PAMs)
B 3 ± 0.5 (24 PAMs)
C 3 ± 0.3 (38 PAMs)
Heat-inactivated foetal bovine 2 ± 0.4 (35 PAMs)
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of M. hyopneumoniae (pMHGFP-P97), and contrary to 
expectation neither did the convalescent sera. It was not 
entirely surprising that a pathogenic organism like M. 
hyopneumoniae exhibited resistance to the bactericidal 
activity of complement. Although M. hyopneumoniae 
appeared resistant to complement killing, deposition of 
complement onto the surface of M. hyopneumoniae cells 
was not determined in this study and could not be ruled 
out.
M. hyopneumoniae convalescent serum had been pur-
posefully excluded from some experiments to mimic the 
in vivo environment of the naïve host, and provide more 
insight into the initial interactions between M. hyopneu‑
moniae and alveolar macrophages. It was surprising 
to find that antibody from three different convalescent 
sera did not promote engulfment of M. hyopneumoniae. 
Other investigators have reported swift uptake of myco-
plasmas such as M. dispar, M. pulmonis, M. ovipneu‑
moniae, M. pneumoniae and M. bovis by macrophages 
following antibody opsonisation [17, 18, 21, 22, 42]. A 
study by Bonnefois et al. [40] investigated uptake of fluo-
rescently labelled M. bovis by monocyte-derived mac-
rophages using confocal microscopy. The fluorescent M. 
bovis were opsonised with pooled bovine convalescent 
serum (ten animals), and within 30  min of co-incuba-
tion green fluorescent clumps of M. bovis were observed 
inside the macrophages. In light of these findings for M. 
bovis it was expected that convalescent serum would 
promote uptake of M. hyopneumoniae (pMHGFP-P97), 
but this was not the case. Although M. hyopneumoniae 
(pMHGFP-P97) were present inside macrophages, the 
number of intracellular mycoplasmas did not differ in 
the presence of naïve or convalescent serum; and intra-
cellular M. hyopneumoniae (pMHGFP-P97) were located 
discreetly in the macrophage cytoplasm. It remains to be 
determined the mechanism by which the mycoplasmas 
entered macrophages. It was assumed that intracellular 
M. hyopneumoniae resulted from phagocytic uptake, yet 
a recent publication has offered a potential alternative 
mechanism. Raymond et al. [37] have suggested that M. 
hyopneumoniae appears to enter PK-15 cells by exploit-
ing clathrin- and caveolae-mediated endocytosis path-
ways; these pathways are available in porcine alveolar 
macrophages [43, 44]. The intracellular M. hyopneumo‑
niae were apparently able to survive fusion of endocytic 
vesicles with lysosomes and escape into the cell cyto-
plasm. So far,  the authors provide only  limited evidence 
that M. hyopneumoniae might invade respiratory epithe-
lial cells in vivo [37]. However, the data presented by Ray-
mond et al. [37] do challenge the long-held belief that M. 
hyopneumoniae is a strict extracellular pathogen.
It is not clear why convalescent sera from experimen-
tally-infected pigs failed to promote phagocytosis of M. 
hyopneumoniae (pMHGFP-P97) in the present inves-
tigation. Two of the convalescent sera, sera B and C, 
were raised against heterologous strains of M. hyopneu‑
moniae compared to M. hyopneumoniae (pMHGFP-
P97) used in the present study. Hence, it is possible 
that strain differences prevented efficient opsonisa-
tion. However, convalescent serum A was produced 
following infection with M. hyopneumoniae strain 232, 
so should have contained antibody recognising sur-
face antigens of M. hyopneumoniae (pMHGFP-P97). 
It is conceivable that the porcine host did not produce 
effective opsonising antibody isotypes IgG1 and IgG3 
in this instance. This raises questions about the efficacy 
of the porcine serum response to M. hyopneumoniae 
infection. Anecdotally, production of antibody follow-
ing M. hyopneumoniae infection can take many weeks 
and does not correlate well with resolution of disease. 
It must be noted that in this investigation the opsonis-
ing powers of mucosal antibody isotypes IgA1 and IgA2 
were not examined. Experimental evidence has sug-
gested that humoral immunity alone is not enough to 
overcome M. hyopneumoniae infection, a cell-mediated 
immune response is also required [8, 45, 46]. An alter-
native explanation may be that M. hyopneumoniae is 
preventing antibody opsonophagocytosis in some way. 
An antibody capture and cleavage system, designated 
MIB-MIP, has been identified in M. mycoides subsp. 
capri which may function as a virulence mechanism 
[47]. The authors identified potential homologues of 
the MIB-MIP system in other Mycoplasma spp. which 
included M. hyopneumoniae. The expression and func-
tionality of a putative M. hyopneumoniae MIB-MIP 
system requires further investigation to determine 
whether this potential virulence mechanism aides M. 
hyopneumoniae in the evasion of humoral effector 
functions such as opsonophagocytosis.
In conclusion, results indicate that M. hyopneumo‑
niae is not readily engulfed by primary porcine alveolar 
macrophages, even in the presence of convalescent por-
cine serum. To strengthen further this observation of 
an antiphagocytic property, different strains of M. hyo‑
pneumoniae could be evaluated following exposure to 
a larger panel of convalescent serum, including serum 
from vaccinated animals; this would also aid analysis of 
the opsonising power of the humoral response against 
M. hyopneumoniae. Overall, this investigation has shed 
more light on the interactions between M. hyopneumo‑
niae and porcine alveolar macrophages, in particular it 
has identified a possible mechanism of immune evasion 
by this important pig pathogen.
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